Topotecan Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2.5 mg, 4 mg/4 mL
Reference Brands: Topotel (USA), Calbitin (USA/EU)
Category:
Oncology Cancer Care
Topotecan is used in the treatment of ovarian cancer.
Topotecan Injection is available in Injection
and strengths such as 2.5 mg, 4 mg/4 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Topotecan Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Topotecan Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Topotecan, marketed under the brand name Hycamtin and other regional brands, is a chemotherapeutic agent belonging to the class of topoisomerase inhibitors. It is a synthetic, water-soluble analog of the natural compound camptothecin and is used in its hydrochloride salt form for medical administration. By inhibiting the enzyme topoisomerase I, Topotecan interferes with DNA replication in rapidly dividing cancer cells, leading to cell death and slowing the progression of tumors.
Topotecan is primarily used for the treatment of ovarian cancer and small cell lung cancer, and it is sometimes employed for other malignancies based on clinical judgment. It is administered intravenously as an injection or, in certain cases, orally in capsule form. Due to its potent cytotoxic effects, careful dosing, patient monitoring, and management of side effects such as myelosuppression, nausea, and hair loss are essential during therapy.
The medication plays a critical role in modern oncology by targeting rapidly proliferating cancer cells while minimizing effects on normal tissues. When used under specialist supervision, Topotecan can help control disease progression, improve patient outcomes, and provide a valuable treatment option for patients with challenging cancers.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing